WILMINGTON, DE — Enovis™ (NYSE: ENOV) has announced Tim Czartoski as the new President of U.S. Surgical and Global Product and Enabling Technologies. Czartoski brings over two decades of experience from his tenure at Depuy Synthes, the Orthopaedics Company of Johnson & Johnson. There, he advanced through various leadership roles, ultimately serving as President of Depuy Synthes, U.S., overseeing joint reconstruction, trauma, spine, digital technology, and sports divisions.
Reporting to Louie Vogt, Group President of Enovis’ Reconstructive Business Group, Czartoski is poised to drive the company’s surgical business and global product development. His academic credentials include a B.S. from Ohio State University, an M.S. in Technology Management from Columbia, and an MBA from Notre Dame.
Louie Vogt expressed confidence in Czartoski’s appointment, stating, “Tim is a highly accomplished orthopedic leader with an incredible track record of delivering strategic and commercial excellence. I’m confident that his experience and leadership will accelerate Enovis’ growth potential and strengthen our surgical pipeline around the world.”
Czartoski’s leadership is expected to propel Enovis towards greater innovation and market presence in the MedTech industry.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.